AstraZeneca and Pfizer Vaccines Effective Against Delta and Kappa Strains of CCP Virus: Study

AstraZeneca and Pfizer Vaccines Effective Against Delta and Kappa Strains of CCP Virus: Study
A doctor puts out syringes with the Pfizer COVID-19 vaccine at a clinic at La Colaborativa in Chelsea, Mass., on June 11, 2021. Brian Snyder/Reuters
Tom Ozimek
Tom Ozimek
Reporter
|Updated:

A new study suggests that COVID-19 vaccines made by AstraZeneca and the Pfizer-BioNTech alliance are broadly effective against the highly contagious Delta and Kappa strains of the CCP (Chinese Communist Party) virus, the pathogen that causes COVID-19.

The Oxford University study, of which a peer-reviewed pre-proof has been published in Cell (pdf), sought to gauge the ability of blood serum from people vaccinated against COVID-19 and from those who recovered naturally to neutralize the Delta (B.1.617.2) and Kappa (B.1.617.1) variants, formerly referred to as the “Indian” variants as that is where they were first observed.
Tom Ozimek
Tom Ozimek
Reporter
Tom Ozimek is a senior reporter for The Epoch Times. He has a broad background in journalism, deposit insurance, marketing and communications, and adult education.
twitter
Related Topics